CO5261594A1 - MYT1 CINASA INHIBITORS - Google Patents
MYT1 CINASA INHIBITORSInfo
- Publication number
- CO5261594A1 CO5261594A1 CO01015772A CO01015772A CO5261594A1 CO 5261594 A1 CO5261594 A1 CO 5261594A1 CO 01015772 A CO01015772 A CO 01015772A CO 01015772 A CO01015772 A CO 01015772A CO 5261594 A1 CO5261594 A1 CO 5261594A1
- Authority
- CO
- Colombia
- Prior art keywords
- substituted
- unsubstituted
- aryl
- group
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
Un compuesto de Fórmula (I), más abajo:<EMI FILE="01015772_1" ID="1" IMF=JPEG >en la que X e Y se seleccionan, independientemente, del grupo que consta de H, Br, CI, CH3, NO2, CN, NR1R2, C=ONR1R2MeO, HO, Me, OR; y un anillo arílico o heteroarílico sustituido independientemente con X e Y;R representa H o alquilo inferior;R1 y R2 se seleccionan independientemente del grupo que consta de H, alquilo inferior, sustituido o no sustituido con X, y un anillo aromático o heterocíclico, sustituido o no sustituido con Y y X;A se selecciona del grupo que consta de O, = O, =NR, =N-NHR3, =NH-NH-CS-NH2, y =NH-NH-CO-NH2; o A es alquilo inferior, sustituido o no sustituido con X, anillo arílico o heteroarílico;o A es un anillo heterocíclico; yR3 se selecciona del grupo que consta de R1, arilo, heteroarilo, C=OR1, C = O-arilo yC=O-heteroarilo, sustituido o no sustituido con X e Y.Un método para antagonizar un receptor de myt1 cinasa que comprende administrar al sujeto que lo necesite una cantidad eficaz de un compuesto según la reivindicación 1.A compound of Formula (I), below: <EMI FILE = "01015772_1" ID = "1" MFI = JPEG> in which X and Y are independently selected from the group consisting of H, Br, CI, CH3 , NO2, CN, NR1R2, C = ONR1R2MeO, HO, Me, OR; and an aryl or heteroaryl ring independently substituted with X and Y; R represents H or lower alkyl; R1 and R2 are independently selected from the group consisting of H, lower alkyl, substituted or unsubstituted with X, and an aromatic or heterocyclic ring, substituted or unsubstituted with Y and X; A is selected from the group consisting of O, = O, = NR, = N-NHR3, = NH-NH-CS-NH2, and = NH-NH-CO-NH2; or A is lower alkyl, substituted or unsubstituted with X, aryl or heteroaryl ring, or A is a heterocyclic ring; and R3 is selected from the group consisting of R1, aryl, heteroaryl, C = OR1, C = O-aryl and C = O-heteroaryl, substituted or unsubstituted with X and Y. A method for antagonizing a myt1 kinase receptor comprising administering to the subject in need an effective amount of a compound according to claim 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18653200P | 2000-03-02 | 2000-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5261594A1 true CO5261594A1 (en) | 2003-03-31 |
Family
ID=22685317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO01015772A CO5261594A1 (en) | 2000-03-02 | 2001-02-28 | MYT1 CINASA INHIBITORS |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001241917A1 (en) |
CO (1) | CO5261594A1 (en) |
WO (1) | WO2001064680A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7423031B2 (en) | 2003-05-01 | 2008-09-09 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
US7385055B2 (en) * | 2003-05-19 | 2008-06-10 | Board Of Trustees Of Michigan State University | Preparation of hymenialdisine derivatives and use thereof |
JP5501251B2 (en) | 2008-01-11 | 2014-05-21 | アルバニー モレキュラー リサーチ, インコーポレイテッド | (1-Azinone) substituted pyridoindoles as MCH antagonists |
EP2448585B1 (en) | 2009-07-01 | 2014-01-01 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof |
US8629158B2 (en) | 2009-07-01 | 2014-01-14 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
US8618299B2 (en) | 2009-07-01 | 2013-12-31 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof |
US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
US8993765B2 (en) | 2010-12-21 | 2015-03-31 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof |
CR20220558A (en) * | 2020-04-01 | 2022-12-12 | Repare Therapeutics Inc | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use |
WO2021195782A1 (en) * | 2020-04-01 | 2021-10-07 | Repare Therapeutics Inc. | Methods of using myt1 inhibitors |
CN115806555A (en) * | 2021-09-16 | 2023-03-17 | 南开大学 | Indolozezinone derivatives, preparation thereof and application thereof in preventing and treating plant viruses, killing insects and killing bacteria |
-
2001
- 2001-02-28 CO CO01015772A patent/CO5261594A1/en not_active Application Discontinuation
- 2001-03-02 WO PCT/US2001/006690 patent/WO2001064680A1/en active Application Filing
- 2001-03-02 AU AU2001241917A patent/AU2001241917A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2001241917A1 (en) | 2001-09-12 |
WO2001064680A1 (en) | 2001-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5280070A1 (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF INDAZOL AND METHODS TO MEASURE OR INHIBIT THE CELL PROLIFERATION | |
CO5390047A1 (en) | DERIVATIVES OF UK-2A | |
CO5261539A1 (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
CO5271657A1 (en) | DERIVATIVES OF AZAINDOL | |
CO5200785A1 (en) | THERAPEUTIC USE OF QUINAZOLINE | |
CO5261594A1 (en) | MYT1 CINASA INHIBITORS | |
AR031597A1 (en) | PIPERIDINE COMPOUNDS, A PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS, AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR USE AS CCR-3 INHIBITORS | |
CO5180626A1 (en) | PURINE DERIVATIVES PROTEIN QUINASA SYK INHIBITORS | |
AR006906A1 (en) | SUBSTITUTED INDAZOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, USE OF THEM AND INTERMEDIARIES OF SYNTHESIS | |
EA200300354A1 (en) | Quinoline derivatives as tyrosine kinase inhibitors | |
CO5170512A1 (en) | TETRAHYDROQUINOLIN PIPERIDINE DERIVATIVES | |
CO5180629A1 (en) | PYRIMIDINE-2,4,6-METALOPROTEINASE INHIBITING TTRIONS | |
CO5640098A2 (en) | BIARILOXIMETILAREN-CARBOXILIC ACIDS | |
EA200300674A1 (en) | OBTAINING HETEROCYCLIC SULPHONAMIDE INHIBITORS BETA-AMYLOID | |
CO5690131A1 (en) | DERIVATIVES OF ETER BIARILICO PRESENTING ACTIVITY AS INHIBITORS OF THE RECOVERY OF MONOAMINS FOR THE TREATMENT OF CNS DISORDERS | |
CO5180605A1 (en) | INDOL COMPOUNDS | |
ES2188194T3 (en) | 1,8-NAFTIRIDIN-4 (1H) -ONON REPLACED AS INHIBITORS OF PHOSPHODESTERASE 4. | |
CO5271675A1 (en) | DECAHIDRO-ISOQUINOLINAS DERIVATIVES, PROCESS FOR THE PREPARATION, COMPOSITION AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM | |
UY26048A1 (en) | DERIVATIVES OF PIRIDOPIRANOACEPINAS, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION | |
CO5271716A1 (en) | CRYSTALS OF 4- CARBOXAMINE 1,2,3,4-TETRAHYDROQUINOLINE 2- REPLACED | |
CO5090829A1 (en) | ORGANIC COMPOUNDS OF FORMULA I, USED AS INHIBITED RES OF THE PROTEIN OF TRANSFER OF MICROSOUS TRIGLICERIDE AND OF THE APOLIPOPROTEIN B SECRETION. | |
CO5420196A1 (en) | INHIBITING COMPOUNDS OF METALOPROTEASE BIDENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS FOR USE | |
CO5261565A1 (en) | INHIBITORS OF N- (5 - (((5-RENT-2-OXAZOLIL) METHYL) TIO) -2-TIAZOLIL) -CARBOXAMIDE OF CYCLINE DEPENDENT KINASES | |
SV2002000244A (en) | METHODS AND COMPOUNDS TO INHIBIT MRP1 REF.X-13353 | |
BRPI0407841A (en) | heterocyclic kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |